# Vitamin B12 Acceptance and Biomarker Response Study

> **NCT01832129** · PHASE4 · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 37 (actual)

## Conditions studied

- Vitamin B 12 Deficiency

## Interventions

- **DRUG:** Oral administration of vitamin B12
- **DRUG:** i.m. injection of vitamin B12

## Key facts

- **NCT ID:** NCT01832129
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2016-06-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01832129

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01832129, "Vitamin B12 Acceptance and Biomarker Response Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01832129. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*